Despite global decrease, Chagas disease is rising in non-endemic regions
On Nov. 6, 2025, the Institute for Health Metrics and Evaluation (IHME) at the University of Washington School…
-
-
WHO publishes new global research agenda to strengthen paediatric clinical trials
On Nov. 6, 2025, the World Health Organization (WHO) released a technical report, The future of paediatric clinical trials…
-
Biotechnology | FDA | Medicine | Therapeutics
Lilly and U.S. government agree to expand access to obesity medicines to millions of Americans
On Nov. 6, 2025, Eli Lilly announced an agreement with the U.S. government to expand access to its…
-
Oxford scientists capture genome’s structure in unprecedented detail
On Nov. 6, 2025, scientists from Oxford’s Radcliffe Department of Medicine have achieved the most detailed view yet…
-
Novo Nordisk announces agreement with the U.S. Administration to bring GLP-1s to more Americans at a lower cost
On Nov. 6, 2025, Novo Nordisk announced it has agreed with the U.S. Administration to lower drug prices…
-
Successful bone regeneration using stem cells derived from fatty tissue
On Nov. 5, 2025, an Osaka Metropolitan University team has used stem cells extracted from adipose, the body’s…
-
Biotechnology | Disease | FDA | Therapeutics
FDA approves menin inhibitor for patients with acute leukemia with NPM1 mutation, backed by Dana-Farber science
On Nov. 4, 2025, the U.S. Food and Drug Administration (FDA) approved revumenib, a first-in-class oral menin inhibitor,…
-
CIRM awards $27 million to launch novel program designed to bring cell and gene therapies to underserved California communities
On Oct. 30, 2025, the California Institute for Regenerative Medicine (CIRM) approved awarding $27 million through three grants…
-
Alice Walton School of Medicine Holds Grand Opening
On Oct. 29, 2025, the Alice L. Walton School of Medicine (AWSOM) celebrated its grand opening on the…
-
Thermo Fisher to buy clinical services provider Clario for up to $9.4 billion
On Oct. 29, 2025, Thermo Fisher announced it would buy privately held data management company Clario for up…
-
Artificial Intelligence | Biotechnology | Chemistry | Energy | Genomics | Infectious Disease | Medical Device | Neurology | Oncology | Pharmaceutical | Stem Cell | Therapeutics | Vaccine
Leiden Report Show Universities in China Dominate Top Ten Rankings
On Oct. 29, 2025, the CWTS Leiden ranking show that Harvard University dropped to third place in the…
-
UNC-led team maps out Phage G genome, the world’s largest cultivated bacteria-killing virus
On Oct. 29, 2025, University of North Carolina at Charlotte (UNC) researchers leading a multidisciplinary team across four…
-
Rice launches Brain Institute to accelerate discoveries in brain science and health
On Oct. 29, 2025, Rice University announced the creation of the Rice Brain Institute (RBI), an ambitious, interdisciplinary…
-
Lilly partners with Nvidia on AI supercomputer to speed up drug development
On Oct. 28, 2025, Eli Lilly announced it was collaborating with Nvidia to build a supercomputer to help…
-
Artificial Intelligence | Biotechnology | Clinical Research | Diagnostics | Disease | Medical Device | Therapeutics
AI-powered diabetes prevention program shows similar benefits to those led by people
On Oct. 27, 2025, researchers from Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health…
-
Qureator Achieves World’s First FDA IND Approval Using Only Human Vascularized Organoid Efficacy Data
On Oct. 27, 2025, Qureator announced a major milestone, confirming a fundamental shift in drug development under the…
-
Rebalancing the Gut: How AI Solved a 25-Year Crohn’s Disease Mystery
On Oct. 27, 2025, researchers at University of California San Diego School of Medicine (UC San Diego) have…
-
Novartis to acquire Avidity Biosciences, an innovator in RNA therapeutics for $11 Billion
On Oct. 26, 2025, Novartis announced that it has entered into an agreement to acquire Avidity Biosciences, a…
-
Lilly to Acquire Adverum Biotechnologies for $12.47 per Share
On Oct. 24, 2025, Eli Lilly and Adverum Biotechnologies announced a definitive agreement for Lilly to acquire Adverum,…
-
Alkermes Announces Agreement to Acquire Avadel Pharmaceuticals for $2.1 billion
On Oct. 22, 2025, Alkermes and Avadel Pharmaceuticals announced the companies have entered into a definitive agreement under…
-
South Carolina Department of Public Health Confirms Measles Outbreak
On Oct. 22, 2025, the South Carolina Department of Public Health (SCDPH) announced it is actively responding to…
-
Pigs developed to be resistant to deadly virus
On Oct. 22, 2025, a Roslin Institute led team announced they have developed pigs that are resistant to…
-
Merck Breaks Ground on $3 Billion Center of Excellence for Pharmaceutical Manufacturing in Elkton, Virginia
On Oct. 20, 2025, Merck announced the start of construction for a $3 billion, 400,000-square-foot pharmaceutical manufacturing facility…
-
Glaukos Announces FDA Approval of Epioxa™
On Oct. 20, 2025, Glaukos announced today the U.S. Food and Drug Administration (FDA) approved its Epioxa™ HD…
-
The Jackson Laboratory acquires New York Stem Cell Foundation to transform biomedical research and accelerate precision therapies for patients
On Oct. 20, 2025, The Jackson Laboratory (JAX), a global leader in genetics and genomic medicine, announced it…
-
ACG to invest $200 million in U.S. hard-shell capsule manufacturing
On Oct. 20, 2025, ACG, the world’s most integrated provider of solid-dosage solutions, announced a $200 million phased…
-
Artificial Intelligence | Biotechnology | CRISPR | CRO | Diagnostics | Genomics | Imaging | Infectious Disease | Medicine | Nanotechnology | Neurology | Oncology | Organoids | Pharmaceutical | Robotics | Stem Cell | Therapeutics | Vaccine | Veterinary | Women's Health
Anthropic launched Claude Life Sciences for research using AI
On Oct. 20, 2025, Anthropic announced a new service called Claude of Life Sciences that uses artificial intelligence…
-
Setback for Roche in Natco Pharma case as India Supreme Court allows generic drug sales
On Oct. 18, 2025, the Swiss Pharma giant F Hoffmann La Roche (Roche) suffered a setback as the…
-
China’s Hansoh signs up to $1.45 billion deal for colorectal cancer drug with Roche
On Oct. 17, 2025, Chinese biotech Hansoh Pharma said it had signed a license agreement worth up to…
-
Boston Scientific Announces Agreement to Acquire Nalu Medical for $533 million
On Oct. 17, 2025, Boston Scientific announced it has entered into a definitive agreement to acquire Nalu Medical,…
